R

Rubius Therapeutics

45 employees

Rubius has developed the technology to grow, genetically engineer and mature long-circulating Red-Cell Therapeutics.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
autoimmune
Therapeutics
science
Pharmaceutical
oncology
platform
biotech
red blood cell

Date founded

2014

Funding rounds raised

Total raised

$120M

from 3 investors over 3 rounds

R

Rubius Therapeutics raised $100M on March 1, 2018

Investors: Flagship Ventures

R

Rubius Therapeutics raised $120M on June 21, 2017

Investors: Flagship Ventures

R

Rubius Therapeutics raised $25M on December 9, 2015

Investors: Flagship Ventures

FAQ